查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1954608

全球军团菌检测市场：市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的分析以及未来预测（2026-2034 年）

Legionella Testing Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 125 Pages | 商品交期: 请询问到货日

价格

军团菌检测市场成长驱动因素

2025 年全球军团菌检测市场规模为 3.793 亿美元，预计将从 2026 年的 4.151 亿美元增长至 2034 年的 8.838 亿美元，预测期内（2026-2034 年）复合年增长率 (CAGR) 为 9.90%。退伍军人病发病率的上升、人们对水传播感染的认识不断提高以及快速诊断技术的广泛应用，推动了该市场的持续稳定成长。 2025 年，北美市场将以 39.50% 的市占率领先，这得益于其完善的监管架构和先进的医疗保健基础设施。

市场概览

军团菌是一种广泛存在于淡水环境中的细菌，例如池塘、湖泊、淋浴间、热水浴池、冷却水塔和储水系统。它们特别在 20°C 至 40°C 的温度条件下繁殖，并可引起退伍军人病和庞蒂亚克热等呼吸道疾病。

已开发国家，特别是针对日益增长的公共卫生问题，已出台了严格的水质定期检测法规。自 1997 年美国退伍军人病病例增加以来，当局已强制要求对供水系统进行检查。根据世界卫生组织（WHO）2022年的数据，美国、欧洲和澳洲每年每百万人中约有10至15例感染病例。

新冠疫情对市场的影响

在新冠疫情期间，由于生产中断、供应链挑战以及医疗系统优先进行新冠病毒检测，市场成长暂时放缓。此外，新冠病毒感染和退伍军人病的临床症状相似，导致军团菌检测率下降。

然而，疫情后时期创造了新的成长机会。建筑物长期关闭导致水系统停滞，增加了军团菌滋生的风险。 2021年，美国疾病管制与预防中心（CDC）建议在设施重新开放前，对热水浴池和储水箱等水系统进行检测。这导致2025年后对军团菌检测解决方案的需求显着增长。

市场趋势

快速检测方法的广泛应用

市场正从传统的培养方法转向先进的诊断技术，例如尿液抗原检测 (UAT) 和聚合酶炼式反应 (PCR)。

  • PCR 检测具有高灵敏度 (95–99%)，可快速检测多种军团菌血清型。 即时 PCR 试剂盒越来越多地应用于医院和现场检测。 快速分子诊断正在提高准确性，并实现疾病的早期发现。

这些技术进步是推动市场成长的主要因素，预计市场规模将从2026年的4.151亿美元成长到2034年的8.838亿美元。

市场成长驱动因素

1.退伍军人症发生率上升

全球病例数的增加推动了对检测试剂盒的需求。根据美国劳工部报告，美国每年约有6,000例军团病病例。医院感染也是一个令人担忧的问题。台湾的一项研究发现，在受调查的医院中，63%的医院的供水系统中检测到了嗜肺军团菌。

2. 严格的监理政策

世界各国正在实施水管理指南。世界卫生组织提供了七份关于风险管理的关键指南文件。在欧洲，欧洲军团病控制工作小组（EWGLI）支援监测计画。这些强化的监管正在推动市场成长。

市场限制因子

儘管成长前景强劲，但发展中国家的认知度较低限制了市场扩张。在印度等国家，由于退伍军人症的症状与肺炎和结核病相似，因此常常难以确诊。此外，新兴市场对即时PCR等先进诊断技术的依赖性低，以及相关基础设施不足，也阻碍了这些技术的普及。

市场区隔分析

依类型

市场依类型细分为培养基、尿抗原检测、PCR、血清学检测和直接免疫萤光检测。

  • 由于尿抗原检测（UAT）价格实惠且当天即可出结果，预计到2026年，UAT将占最大的市场占有率，达到42.12%。然而，UAT主要检测的是LP1。
  • 由于PCR检测具有更高的灵敏度和准确性，因此预计其市场成长速度最快。

依最终使用者划分

细分市场包括医院和诊所、临床实验室、环境检测机构。

  • 临床实验室占市场主导地位，预计由于疾病流行率上升和先进诊断技术的普及，将继续保持领先地位。
  • 由于现场检测解决方案和监管要求，环境检测正在迅速发展。

区域洞察

北美

预计2025年，北美市场规模将达到1.4965亿美元。强而有力的监管、较高的健康意识以及庞大的老年人口是推动市场需求的主要因素。

欧洲

由于疫情蔓延和PCR检测的引入，欧洲占了第二大市场占有率。

亚太地区

在医疗基础设施改善和公众意识提高的推动下，亚太地区预计到2034年将以最高的复合年增长率增长。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：主要发现

  • 全球市场主要趋势
  • 新产品发布与核准：依主要公司划分
  • 关键趋势：併购、业务合作等
  • 最新技术进展
  • 监理环境洞察
  • 波特五力分析
  • 关税对市场的影响

第四章 主要考虑因素

  • 军团菌感染爆发：依主要国家划分
  • 关键产业趋势：併购、业务合作
  • 军团菌检测试剂盒的技术进步
  • 主要国家的监管状况
  • 新冠疫情对市场的影响

第五章 全球军团菌检测市场分析：洞察与预测（2021-2034）

  • 市场分析、洞察与预测：依国家划分类型
    • 培养基
    • 尿抗原检测 (UAT)
    • 聚合酶炼式反应 (PCR)
    • 血清学
    • 直接免疫萤光 (DFA)
  • 市场分析、洞察与预测：依最终用户划分
    • 医院和诊所
    • 临床实验室
    • 其他
  • 市场分析、洞察与预测：依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章 北美军团菌检测市场分析：洞察与预测 (2021-2034)

  • 依国家划分
    • 美国州/省
    • 加拿大

第七章 欧洲军团菌检测市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他欧洲国家

第八章 亚太地区军团菌检测市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 中国
    • 日本
    • 韩国
    • 印度
    • 澳大利亚
    • 台湾
    • 印尼
    • 其他亚太地区

章节9 拉丁美洲军团菌检测市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲国家

第 10 章 中东与非洲军团菌检测市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 海湾合作委员会 (GCC) 国家
    • 南非
    • 其他中东和非洲国家

第11章 竞争分析

  • 全球市场占有率分析(2025年)
  • 企业简介
    • Quidel Corporation
    • Abbott
    • Merck KGaA
    • Bio-Rad Laboratories, Inc.
    • Thermo Fisher Scientific Inc.
    • BD
    • bioMerieux
    • IDEXX Corporation
    • Eurofins Scientific
Product Code: FBI102803

Growth Factors of Legionella testing Market

The global Legionella testing market was valued at USD 379.3 million in 2025 and is projected to grow from USD 415.1 million in 2026 to USD 883.8 million by 2034, exhibiting a CAGR of 9.90% during the forecast period (2026-2034). The market is witnessing steady expansion due to the rising prevalence of Legionnaires' disease, increasing awareness regarding waterborne infections, and the growing adoption of rapid diagnostic technologies. In 2025, North America dominated the market with a 39.50% share, supported by strong regulatory frameworks and advanced healthcare infrastructure.

Market Overview

Legionella is a bacterial species commonly found in freshwater environments such as ponds, lakes, showers, hot tubs, cooling towers, and water storage systems. Under favorable conditions, particularly temperatures between 20°C and 40°C, the bacteria multiply and can cause respiratory illnesses such as Legionnaires' disease and Pontiac fever.

Growing public health concerns, especially in developed countries, have led to stringent regulations for regular water testing. Following the increased prevalence of Legionella infections in the U.S. since 1997, authorities implemented mandatory testing of water systems. According to WHO data (2022), approximately 10-15 cases per million population are detected annually across the U.S., Europe, and Australia.

Impact of COVID-19 on the Market

During the COVID-19 pandemic, the market experienced temporary slow growth due to manufacturing disruptions, supply chain challenges, and healthcare systems prioritizing coronavirus testing. Additionally, similarities in clinical symptoms between COVID-19 and Legionnaires' disease resulted in reduced Legionella testing rates.

However, the post-pandemic period has created renewed growth opportunities. Prolonged building closures led to stagnant water systems, increasing the risk of Legionella proliferation. In 2021, the CDC recommended testing water systems such as hot tubs and storage tanks before reopening facilities. This has significantly boosted demand for Legionella testing solutions in 2025 and beyond.

Market Trends

Growing Adoption of Rapid Testing Methods

The market is witnessing a shift from traditional culture methods to advanced diagnostic technologies such as Urine Antigen Testing (UAT) and Polymerase Chain Reaction (PCR).

  • PCR testing offers high sensitivity (95-99%) and detects multiple Legionella serotypes with faster turnaround times.
  • Real-time PCR kits are increasingly adopted for hospital-based and onsite testing.
  • Rapid molecular diagnostics are improving accuracy and enabling early disease detection.

These technological advancements are key contributors to the projected growth from USD 415.1 million in 2026 to USD 883.8 million by 2034.

Market Growth Drivers

1. Rising Prevalence of Legionnaires' Disease

Increasing global cases are driving demand for testing kits. The U.S. Department of Labor reports approximately 6,000 Legionella cases annually in the U.S. Hospital-acquired infections are also a concern. A study in Taiwan revealed that 63% of surveyed hospitals tested positive for Legionella pneumophila in their water systems.

2. Stringent Regulatory Policies

Governments worldwide are enforcing water management guidelines. The WHO provides seven principal guidance documents for risk management. In Europe, the European Working Group for Legionella Infections (EWGLI) supports surveillance programs. Such regulatory emphasis is strengthening market growth.

Market Restraints

Despite strong growth prospects, limited awareness in underdeveloped countries restrains market expansion. In countries like India, Legionella infections are often underdiagnosed due to overlapping symptoms with pneumonia and tuberculosis. High costs of advanced diagnostics such as real-time PCR and lack of infrastructure also hinder adoption in emerging markets.

Segmentation Analysis

By Type

The market is segmented into culture media, urine antigen testing, PCR, serology tests, and direct fluorescent antibody methods.

  • Urine Antigen Testing (UAT) held the largest market share of 42.12% in 2026, due to affordability and same-day results. However, it primarily detects LP1 species.
  • PCR testing is projected to witness the fastest growth due to superior sensitivity and accuracy.

By End-User

Segments include hospitals & clinics, clinical laboratories, and environmental testing sites.

  • Clinical laboratories dominated the market and are expected to maintain leadership due to rising disease prevalence and advanced diagnostic penetration.
  • Environmental testing is expanding rapidly due to onsite testing solutions and regulatory mandates.

Regional Insights

North America

The market size in North America reached USD 149.65 million in 2025. Strong regulatory enforcement, high awareness, and a large geriatric population drive demand.

Europe

Europe holds the second-largest share due to increasing outbreaks and adoption of PCR testing.

Asia Pacific

Asia Pacific is projected to grow at the highest CAGR through 2034, supported by improving healthcare infrastructure and rising awareness.

Competitive Landscape

The market is consolidated, with key players including Abbott, Thermo Fisher Scientific, Bio-Rad Laboratories, Merck KGaA, IDEXX Corporation, BD, bioMerieux, and Eurofins Scientific. Companies are focusing on mergers, acquisitions, and product launches to expand their portfolios.

Conclusion

The global Legionella testing market is set for strong growth, rising from USD 379.3 million in 2025 to USD 883.8 million by 2034, driven by increasing disease prevalence, stringent water safety regulations, and rapid adoption of advanced diagnostic technologies such as PCR and UAT. While limited awareness in emerging economies poses challenges, expanding regulatory frameworks and technological innovations are expected to sustain long-term market expansion. As governments and healthcare institutions prioritize water safety and infection prevention, Legionella testing will remain a critical component of global public health strategies.

Segmentation

By Type

  • Culture Media
  • Urine Antigen Testing (UAT)
  • Polymerase Chain Reaction (PCR)
  • Serology
  • Direct Fluorescent Antibody (DFA) Test

By End-User

  • Hospitals & Clinics
  • Clinical Laboratories
  • Others

By Geography

  • North America (By Type, End-User, and Country)
    • U.S.
    • Canada
  • Europe (By Type, End-User, and Country/Sub region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific (By Type, End-User, and Country/Sub region)
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Taiwan
    • Indonesia
    • Rest of Asia Pacific
  • Latin America (By Type, End-User, and Country/Sub region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, End-User, and Country/Sub region)
    • South Africa
    • GCC
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Legionella Infection, By Key Countries
  • 4.2. Key Industry Developments - Merges, Acquisitions and Partnerships
  • 4.3. Technological Advancements in Legionella Testing Kits
  • 4.4. Regulatory Scenario, By Key Countries
  • 4.5. Impact of COVID-19 on the Market

5. Global Legionella Testing Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Culture Media
    • 5.1.2. Urine Antigen Testing (UAT)
    • 5.1.3. Polymerase Chain Reaction (PCR)
    • 5.1.4. Serology
    • 5.1.5. Direct Fluorescent Antibody Test (DFA)
  • 5.2. Market Analysis, Insights and Forecast - By End User
    • 5.2.1. Hospitals & Clinics
    • 5.2.2. Clinical Laboratories
    • 5.2.3. Others
  • 5.3. Market Analysis, Insights and Forecast - By Region
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia Pacific
    • 5.3.4. Latin America
    • 5.3.5. Middle East & Africa

6. North America Legionella Testing Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Culture Media
    • 6.1.2. Urine Antigen Testing (UAT)
    • 6.1.3. Polymerase Chain Reaction (PCR)
    • 6.1.4. Serology
    • 6.1.5. Direct Fluorescent Antibody Test (DFA)
  • 6.2. Market Analysis, Insights and Forecast - By End User
    • 6.2.1. Hospitals & Clinics
    • 6.2.2. Clinical Laboratories
    • 6.2.3. Others
  • 6.3. Market Analysis, Insights and Forecast - By Country
    • 6.3.1. U.S.
    • 6.3.2. Canada

7. Europe Legionella Testing Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Culture Media
    • 7.1.2. Urine Antigen Testing (UAT)
    • 7.1.3. Polymerase Chain Reaction (PCR)
    • 7.1.4. Serology
    • 7.1.5. Direct Fluorescent Antibody Test (DFA)
  • 7.2. Market Analysis, Insights and Forecast - By End User
    • 7.2.1. Hospitals & Clinics
    • 7.2.2. Clinical Laboratories
    • 7.2.3. Others
  • 7.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.3.1. U.K
    • 7.3.2. Germany
    • 7.3.3. France
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Rest of Europe

8. Asia Pacific Legionella Testing Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Culture Media
    • 8.1.2. Urine Antigen Testing (UAT)
    • 8.1.3. Polymerase Chain Reaction (PCR)
    • 8.1.4. Serology
    • 8.1.5. Direct Fluorescent Antibody Test (DFA)
  • 8.2. Market Analysis, Insights and Forecast - By End User
    • 8.2.1. Hospitals & Clinics
    • 8.2.2. Clinical Laboratories
    • 8.2.3. Others
  • 8.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
    • 8.3.4. India
    • 8.3.5. Australia
    • 8.3.6. Taiwan
    • 8.3.7. Indonesia
    • 8.3.8. Rest of Asia Pacific

9. Latin America Legionella Testing Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Culture Media
    • 9.1.2. Urine Antigen Testing (UAT)
    • 9.1.3. Polymerase Chain Reaction (PCR)
    • 9.1.4. Serology
    • 9.1.5. Direct Fluorescent Antibody Test (DFA)
  • 9.2. Market Analysis, Insights and Forecast - By End User
    • 9.2.1. Hospitals & Clinics
    • 9.2.2. Clinical Laboratories
    • 9.2.3. Others
  • 9.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 9.3.1. Brazil
    • 9.3.2. Mexico
    • 9.3.3. Rest of Latin America

10. Middle East & Africa Legionella Testing Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Culture Media
    • 10.1.2. Urine Antigen Testing (UAT)
    • 10.1.3. Polymerase Chain Reaction (PCR)
    • 10.1.4. Serology
    • 10.1.5. Direct Fluorescent Antibody Test (DFA)
  • 10.2. Market Analysis, Insights and Forecast - By End User
    • 10.2.1. Hospitals & Clinics
    • 10.2.2. Clinical Laboratories
    • 10.2.3. Others
  • 10.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 10.3.1. GCC
    • 10.3.2. South Africa
    • 10.3.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Quidel Corporation
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. financials (Based on Availability)
    • 11.2.2. Abbott
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. financials (Based on Availability)
    • 11.2.3. Merck KGaA
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. financials (Based on Availability)
    • 11.2.4. Bio-Rad Laboratories, Inc.
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. financials (Based on Availability)
    • 11.2.5. Thermo Fisher Scientific Inc.
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. financials (Based on Availability)
    • 11.2.6. BD
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. financials (Based on Availability)
    • 11.2.7. bioMerieux
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. financials (Based on Availability)
    • 11.2.8. IDEXX Corporation
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. financials (Based on Availability)
    • 11.2.9. Eurofins Scientific
      • 11.2.9.1. Overview
      • 11.2.9.2. Products
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. financials (Based on Availability)

List of Tables

  • Table 1: Global Legionella Testing Market Revenue (USD Million) Forecast, by Type, 2021-2034
  • Table 2: Global Legionella Testing Market Revenue (USD Million) Forecast, by End-user, 2021-2034
  • Table 3: Global Legionella Testing Market Revenue (USD Million) Forecast, by Region, 2021-2034
  • Table 4: North America Legionella Testing Market Revenue (USD Million) Forecast, by Type, 2021-2034
  • Table 5: North America Legionella Testing Market Revenue (USD Million) Forecast, by End-user, 2021-2034
  • Table 6: North America Legionella Testing Market Revenue (USD Million) Forecast, by Country, 2021-2034
  • Table 7: Europe Legionella Testing Market Revenue (USD Million) Forecast, by Type, 2021-2034
  • Table 8: Europe Legionella Testing Market Revenue (USD Million) Forecast, by End-user, 2021-2034
  • Table 9: Europe Legionella Testing Market Revenue (USD Million) Forecast, by Country/ Sub-region, 2021-2034
  • Table 10: Asia Pacific Legionella Testing Market Revenue (USD Million) Forecast, by Type, 2021-2034
  • Table 11: Asia Pacific Legionella Testing Market Revenue (USD Million) Forecast, by End-user, 2021-2034
  • Table 12: Asia Pacific Legionella Testing Market Revenue (USD Million) Forecast, by Country/ Sub-region, 2021-2034
  • Table 13: Latin America Legionella Testing Market Revenue (USD Million) Forecast, by Type, 2021-2034
  • Table 14: Latin America Legionella Testing Market Revenue (USD Million) Forecast, by End-user, 2021-2034
  • Table 15: Latin America Legionella Testing Market Revenue (USD Million) Forecast, by Country/ Sub-region, 2021-2034
  • Table 16: Middle East & Africa Legionella Testing Market Revenue (USD Million) Forecast, by Type, 2021-2034
  • Table 17: Middle East & Africa Legionella Testing Market Revenue (USD Million) Forecast, by End-user, 2021-2034
  • Table 18: Middle East & Africa Legionella Testing Market Revenue (USD Million) Forecast, by Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Legionella Testing Market Revenue Breakdown (USD Million, %) by Region, 2025 & 2034
  • Figure 2: Global Legionella Testing Market Value Share (%), by Type, 2025 & 2034
  • Figure 3: Global Legionella Testing Market Forecast (USD Million), by Culture Media, 2021-2034
  • Figure 4: Global Legionella Testing Market Forecast (USD Million), by Urine Antigen Testing (UAT), 2021-2034
  • Figure 5: Global Legionella Testing Market Forecast (USD Million), by Polymerase Chain Reaction (PCR), 2021-2034
  • Figure 6: Global Legionella Testing Market Forecast (USD Million), by Serology, 2021-2034
  • Figure 7: Global Legionella Testing Market Forecast (USD Million), by Direct Fluorescent Antibody Test (DFA), 2021-2034
  • Figure 8: Global Legionella Testing Market Value Share (%), by End-user, 2025 & 2034
  • Figure 09: Global Legionella Testing Market Value (USD Million), by Region, 2025 & 2034
  • Figure 10: North America Legionella Testing Market Value (USD Million), by Type, 2025 & 2034
  • Figure 11: North America Legionella Testing Market Value Share (%), by Type, 2025
  • Figure 12: North America Legionella Testing Market Value (USD Million), by End-user, 2025 & 2034
  • Figure 13: North America Legionella Testing Market Value Share (%), by End-user, 2025
  • Figure 14: North America Legionella Testing Market Value (USD Million), by Country, 2025 & 2034
  • Figure 15: North America Legionella Testing Market Value Share (%), by Country, 2025
  • Figure 16: Europe Legionella Testing Market Value (USD Million), by Type, 2025 & 2034
  • Figure 17: Europe Legionella Testing Market Value Share (%), by Type, 2025
  • Figure 18: Europe Legionella Testing Market Value (USD Million), by End-user, 2025 & 2034
  • Figure 19: Europe Legionella Testing Market Value Share (%), by End-user, 2025
  • Figure 20: Europe Legionella Testing Market Value (USD Million), by Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Legionella Testing Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Legionella Testing Market Value (USD Million), by Type, 2025 & 2034
  • Figure 23: Asia Pacific Legionella Testing Market Value Share (%), by Type, 2025
  • Figure 24: Asia Pacific Legionella Testing Market Value (USD Million), by End-user, 2025 & 2034
  • Figure 25: Asia Pacific Legionella Testing Market Value Share (%), by End-user, 2025
  • Figure 26: Asia Pacific Legionella Testing Market Value (USD Million), by Country/ Sub-region, 2025 & 2034
  • Figure 27: Asia Pacific Legionella Testing Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 28: Latin America Legionella Testing Market Value (USD Million), by Type, 2025 & 2034
  • Figure 29: Latin America Legionella Testing Market Value Share (%), by Type, 2025
  • Figure 30: Latin America Legionella Testing Market Value (USD Million), by End-user, 2025 & 2034
  • Figure 31: Latin America Legionella Testing Market Value Share (%), by End-user, 2025
  • Figure 32: Latin America Legionella Testing Market Value (USD Million), by Country/ Sub-region, 2025 & 2034
  • Figure 33: Latin America Legionella Testing Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 34: Middle East & Africa Legionella Testing Market Value (USD Million), by Type, 2025 & 2034
  • Figure 35: Middle East & Africa Legionella Testing Market Value Share (%), by Type, 2025
  • Figure 36: Middle East & Africa Legionella Testing Market Value (USD Million), by End-user, 2025 & 2034
  • Figure 37: Middle East & Africa Legionella Testing Market Value Share (%), by End-user, 2025
  • Figure 38: Middle East & Africa Legionella Testing Market Value (USD Million), by Country/ Sub-region, 2025 & 2034
  • Figure 39: Middle East & Africa Legionella Testing Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 40: Global Legionella Testing Market Share (%), By Company, 2025